SVB Leerink Starts Shockwave Medical (SWAV) at Outperform
- Nasdaq tumbles 2% on weak data, surging bond yields
- Ford (F) Stock Soars on $11.4 Billion EV Partnership with Battery Maker SK Innovation (SKOVF)
- Brent oil near $80 a barrel on tighter supplies
- Piper Sandler Raises Estimates on Tesla (TSLA) Ahead of 'Best-Ever Quarter' in Q3
- Buy-the-dip Mentality Continues to Dominate, Last Week's $5.9 Billion Stock Inflows Were Fourth Largest Since 2008 - BofA
SVB Leerink analyst Danielle Antalffy initiates coverage on Shockwave Medical (NASDAQ: SWAV) with a Outperform rating and a price target of $208.00.
Shares of Shockwave Medical closed at $171.63 yesterday.
You May Also Be Interested In
- Barclays Starts Leroy Seafood Group ASA (LSG:NO) at Underweight
- UPDATE: Evercore ISI Starts UPS (UPS) at Outperform
- BofA Securities Reinstates Equitrans Midstream Corp. (ETRN) at Neutral
Create E-mail Alert Related CategoriesNew Coverage
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!